Artificial Intelligence-Aided Endoscopy and Colorectal Cancer Screening
- PMID: 36980409
- PMCID: PMC10047293
- DOI: 10.3390/diagnostics13061102
Artificial Intelligence-Aided Endoscopy and Colorectal Cancer Screening
Abstract
Colorectal cancer (CRC) is the third most common cancer worldwide, with the highest incidence reported in high-income countries. However, because of the slow progression of neoplastic precursors, along with the opportunity for their endoscopic detection and resection, a well-designed endoscopic screening program is expected to strongly decrease colorectal cancer incidence and mortality. In this regard, quality of colonoscopy has been clearly related with the risk of post-colonoscopy colorectal cancer. Recently, the development of artificial intelligence (AI) applications in the medical field has been growing in interest. Through machine learning processes, and, more recently, deep learning, if a very high numbers of learning samples are available, AI systems may automatically extract specific features from endoscopic images/videos without human intervention, helping the endoscopists in different aspects of their daily practice. The aim of this review is to summarize the current knowledge on AI-aided endoscopy, and to outline its potential role in colorectal cancer prevention.
Keywords: cancer; colonoscopy; innovation; screening; technology.
Conflict of interest statement
M.S.: none. D.M.: none. Y.M.: consulting for Olympus Corp.; ownership interest in Cybernet Corp. L.A.: none. A.F.: none. R.M.: consulting fees for Fuji. P.S.: consulting fees for Fuji. C.H.: consulting fees for Fuji and Medtronic. A.R.: consulting fees for Fuji, Olympus, and Medtronic.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
